http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_948cb50b7d4e971500793aaa7f5e5a8b
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Aparicio |
| name | Ana Aparicio |
| given-name | Ana |
| organization-name | From the Department of Genitourinary Medical Oncology, University of Texas M.D. Anderson Cancer Center, Houston. Authors' Affiliations: Departments of 1Genitourinary Medical Oncology, 2Translational Molecular Pathology, and 3The David H. Koch Center for the Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas; Authors' Affiliations: Departments of 1Genitourinary Medical Oncology, 2Translational Molecular Pathology, and 3The David H. Koch Center for the Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas Division of Medical Oncology, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles 90033, USA. aaparici@usc.edu From the Departments of Genitourinary Medical Oncology; Urology; Pathology; and Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, TX. Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA Authors' Affiliation: Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas Ana Aparicio and Christopher J. Logothetis, MD Anderson Cancer Center, Houston, TX CIBERehd, Madrid, Spain;; Hospital Universitario Reina Sofía, Córdoba, Spain; Department of Psychiatry Hospital Virgen de la Luz Cuenca Spain The University of Texas MD Anderson Cancer Center , Houston, TX , USA 4University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, California; and Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030; Authors' Affiliations: 1Division of Hematology and Medical Oncology; 2Institute for Precision Medicine, New York Presbyterian; 3Department of Pathology and Laboratory Medicine, Weill Cornell Medical College; 4Department of Oncology, Memorial Sloan Kettering, New York, New York; 5Department of Pathology, University of Michigan, Ann Arbor, Michigan; 6Department of Oncology, The University of Texas MD Anderson Cancer Center; 7Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center, Houston, Texas; 8Department of Pathology and Laboratory Medicine, University of California, Los Angeles (UCLA), Los Angeles; 9Prostate Cancer Foundation, Santa Monica, California; 10Department of Pathology, University of Washington, Seattle, Washington; and 11Vancouver Prostate Centre, Vancouver, British Columbia, Canada Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston Department of Genitourinary Medical Oncology University of Texas MD Anderson Cancer Center Houston Texas 1Department of Genitourinary Medical Oncology, David H. Koch Center for Applied Research of Genitourinary Cancers, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Department of Genitourinary Medical Oncology The University of Texas MD Anderson Cancer Center Houston Texas USA |
Incoming Links
Total number of triples: 87.